NCT04674111 - Vortex - Temporary Percutaneous, Transvalvular Circulatory Support System Feasibility Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 28, 2021

Primary Completion Date

April 8, 2022

Study Completion Date

April 8, 2022

Conditions

Coronary Artery Disease

Interventions

DEVICE

Temporary Percutaneous Transvalvular Circulatory Support System (Vortex System)

The Vortex System is intended to provide temporary circulatory support in subjects undergoing elective high-risk percutaneous coronary intervention (HR-PCI).

Trial Locations (2)

3004

The Alfred Hospital, Melbourne

222-42

Skane University Hospital, Lund